VX2 carcinoma in rabbits after radiofrequency ablation: Comparison of MR contrast agents for help in differentiating benign periablational enhancement from residual tumor

Radiology

Volumn 234, Issue 2, 2005, Pages 423-430

  Kim, Tae Jung ^a,b   Moon, Woo Kyung ^a,b   Cha, Joo Hee ^a   Goo, Jin Mo ^a   Lee, Kyoung Ho ^a   Kim, Keon Ha ^a   Lee, Joon Woo ^a   Han, Joon Goo ^a   Weinmann, Hanns Joachim ^c   Chang, Kee Hyun ^a  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Dept of Contrast Media Research ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM PENTETATE; SH L 643A; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARCINOMA VX2; CONTROLLED STUDY; HISTOPATHOLOGY; IMAGE ENHANCEMENT; LIVER CELL CARCINOMA; MICROVASCULATURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION;

ANIMALS; CATHETER ABLATION; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; GADOLINIUM; GADOLINIUM DTPA; MAGNETIC RESONANCE IMAGING; NEOPLASM, RESIDUAL; NEOPLASMS, EXPERIMENTAL; PROSPECTIVE STUDIES; RABBITS;

EID: 19944432690     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2342031456     Document Type: Article

References (31)

1. Wood BJ, Ramkaransingh JR, Fojo T, Walther MM, Libutti SK. Percutaneous tumor ablation with radiofrequency. Cancer 2002; 94: 443-451.
2. Mlrza AN, Fornage BD, Sneige N, et al. Radiofrequency ablation of solid tumors. Cancer J 2001; 7:95-102.
3. Nahum Goldberg S, Dupuy DE. Image-guided radiofrequency tumor ablation: challenges and opportunities-part 1. J Vasc Interv Radiol 2001; 12:1021-1032.
4. Kuszyk BS, Boitnott JK, Choti MA, et al. Local tumor recurrence following hepatic cryoablation: radiologic-histopathologic correlation in a rabbit model. Radiology 2000; 217:477-486.
5. Choi H, Loyer EM, DuBrow RA, et al. Radiofrequency ablation of liver tumors: assessment of therapeutic response and complications. RadioGraphics 2001; 21(special issue): S41-S54.
6. Dromain C, de Baere T, Elias D, et al. Hepatic tumors treated with percutaneous radio-frequency ablation: CT and MR imaging follow-up. Radiology 2002; 223:255-262.
7. Goldberg SN, Gazelle GS, Solbiati L, et al. Ablation of liver tumors using percutaneous RF therapy. AJR Am J Roentgenol 1998; 170: 1023-1028.
8. Raman SS, Lu DS, Vodopich DJ, Sayre J, Lassman C. Creation of radiofrequency residual tumor and post-ablative changes in a porcine model: correlation with sonography, CT, and histopathology. AJR Am J Roentgenol 2000; 175:1253-1258.
9. Sironi S, Livraghi T, Meloni F, De Cobelli F, Ferrero C, Del Maschio A. Small hepatocellular carcinoma treated with percutaneous RF ablation: MR imaging follow-up. AJR Am J Roentgenol 1999; 173:1225-1229.
10. Goldberg SN, Charboneau JW, Dodd GD 3rd, et al. Image-guided tumor ablation: proposal for standardization of terms and reporting criteria. Radiology 2003; 228:335-345.
11. Brasch RC. Rationale and applications for macromolecular Gd-based contrast agents. Magn Reson Med 1991; 22:282-287.
12. Misselwitz B, Schmitt-Willich H, Ebert W, Frenzel T, Weinmann HJ. Pharmacokinetics of Gadomer-17, a new dendritic magnetic resonance contrast agent. MAGMA 2001; 12: 128-134.
13. Grist TM, Korosec FR, Peters DC, et al. Steady-state and dynamic MR angiography with MS-325: initial experience in humans. Radiology 1998; 207:539-544.
14. Daldrup H, Shames DM, Wendland M, et al. Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media. AJR Am J Roentgenol 1998; 171:941-949.
15. Demsar F, Roberts TP, Schwickert HC, et al. A MRI spatial mapping technique for microvascular permeability and tissue blood volume based on macromolecular contrast agent distribution. Magn Reson Med 1997; 37:236-242.
16. Brasch R, Pham C, Shames D, et al. Assessing tumor angiogenesis using macromolecular MR imaging contrast media. J Magn Reson Imaging 1997; 7:68-74.
17. Li D, Zheng J, Weinmann HJ. Contrast-enhanced MR imaging of coronary arteries: comparison of intra- and extravascular contrast agents in swine. Radiology 2001; 218: 670-678.
18. Jain RK. Transport of molecules across tumor vasculature. Cancer Metastasis Rev 1987; 6:559-593.
19. Miao Y, Ni Y, Mulier S, et al. Treatment of VX2 liver tumor in rabbits with "wet" electrode mediated radio-frequency ablation. Eur Radiol 2000; 10:188-194.
20. Lee JW, Moon WK, Weinmann HJ, et al. Contrast-enhanced MR imaging of postoperative scars and VX2 carcinoma in rabbits: comparison of macromolecular contrast agent and gadopentetate dimeglumine. Radiology 2003; 229:132-139.
21. Henderson E, Sykes J, Drost D, Weinmann HJ, Rutt BK, Lee TY. Simultaneous MRI measurement of blood flow, blood volume, and capillary permeability in mammary tumors using two different contrast agents. J Magn Reson Imaging 2000; 12:991-1003.
22. Verhoye M, van der Sanden BP, Rijken PF, et al. Assessment of the neovascular permeability in glioma xenografts by dynamic T1 MRI with Gadomer-17. Magn Reson Med 2002; 47:305-313.
23. Weinmann HJ, Brasch RC, Press WR, Wesbey GE. Characteristics of gadolinium-DTPA complex: a potential new NMR contrast agent. AJR Am J Roentgenol 1984; 142:619-624.
24. Moon WK, Chang KH, Weinmann HJ, et al. Dynamic contrast-enhanced MR imaging of bacterial abscess and VX2 carcinoma in rabbits: comparison of gadopentetate dimeglumine and a macromolecular contrast agent. AJR Am J Roentgenol 2000; 174:1385-1390.
25. Tacke J, Adam G, Classen H, Muhler A, Prescher A, Gunther RW. Dynamic MRI of a hypovascularized liver tumor model: comparison of a new blood pool contrast agent (24-gadolinium-DTPA-cascade-polymer) with gadopentetate dimeglumine. J Magn Reson Imaging 1997; 7:678-682.
26. Adam G, Muhler A, Spuntrup E, et al. Differentiation of spontaneous canine breast tumors using dynamic magnetic resonance imaging with 24-gadolinium-DTPA-cascade-polymer, a new blood-pool agent: preliminary experience. Invest Radiol 1996; 31:267-274.
27. Nguyen-minh C, Haughton VM, An HS, You JW, Wook S, Ho KC. Contrast media of high and low molecular weights in the detection of recurrent herniated disks. AJNR Am J Neuroradiol 1998; 19:889-893.
28. Merkle EM, Boll DT, Boaz T, et al. MRI-guided radiofrequency thermal ablation of implanted VX2 liver tumors in a rabbit model: demonstration of feasibility at 0.2 T. Magn Reson Med 1999; 42:141-149.
29. Lee JD, Lee JM, Kim SW, Kim CS, Mun WS. MR imaging-histopathologic correlation of radiofrequency thermal ablation lesion in a rabbit model: observation during acute and chronic stages. Korean J Radiol 2001; 2:151-158.
30. Goldberg SN, Gazelle GS, Compton CC, Mueller PR, Tanabe KK. Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation. Cancer 2000; 88:2452-2463.
31. Sugimori K, Morimoto M, Sharito K, et al. Radiofrequency ablation in a pig liver model: effect of transcatheter arterial embolization on coagulation diameter and histologic characteristics. Hepatol Res 2002; 24:164-173.